Sort by
Refine Your Search
-
Listed
-
Field
-
academic research and associated activities. This is a fixed-term position for 12 months, funded by Cancer Research UK. Applications for this vacancy are to be made online. You will be required to upload a
-
A one-year Research Assistant position is available in Prof Ivan Ahel’s group based in the Sir William Dunn School of Pathology, University of Oxford to study ADP-ribosylation signalling in DNA
-
full time, fixed term position for 24 months. We are seeking a motivated Postdoctoral Research Assistant to participate in a research project in the Biophysical Immunology (www.bpi-oxford.com) Lab led by
-
the covering letter/supporting statement (describing how you meet the criteria), a CV, and names of two academic references. The position is a full-time fixed term post available until 31 December 2025
-
statement (describing how you meet the criteria), a CV, and names of two academic references. The position is a full-time fixed term post available to 31 December 2027. The closing date for applications is
-
We invite applications for a Postdoctoral Research Associate to join a research project funded by an EPSRC grant. The position is offered on a fixed-term basis until 31 August 2026, with a maximum
-
. The position is a full-time fixed term post available for 12 months. The closing date for applications is 12.00 noon on Friday 08 August 2025 Informal enquiries may be addressed to Prof Noa Zilberman
-
research interests (describing how past experience and future plans fit with the advertised position), CV and the details of two referees as part of your online application. The Department holds an Athena
-
managing a discrete area of a research project is desirable. Due to the nature of the research at the Kennedy Institute of Rheumatology, this job will require additional security pre-employment checks
-
, focuses on the construction and testing of novel vaccines and evaluating new anti-mycobacterial drugs to improve treatment outcomes. This position will involve evaluating novel vaccine candidates and drugs